Table 4 Cost effectiveness of TLH versus TAH for uterine fibroids
| Â | Adjusted difference (95% CIs) |
|---|---|
Increment costs, 2020 US$ | 256.86 (249.03, 264.69) |
Increment effect | |
Rate of major surgical complications, % | -4.53 (-4.71, -4.35) |
Rate of discomfort symptoms, % | -6.75 (-7.05, -6.45) |
Time to normal activity, weeks | -1.27 (-1.30, -1.23) |
ICER (Rate of major surgical complications) | -56.69 (-59.55, -53.84) |
ICER (Rate of discomfort symptoms) | -38.02 (-39.68, -36.35) |
ICER (Time to normal activity) | -202.96 (-210.95, -194.97) |